These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33461829)

  • 1. Improving retention across the OUD service cascade upon reentry from jail using Recovery Management Checkups-Adaptive (RMC-A) experiment.
    Scott CK; Dennis ML; Grella CE; Watson DP
    J Subst Abuse Treat; 2021 Sep; 128():108245. PubMed ID: 33461829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail.
    Howell BA; Puglisi L; Clark K; Albizu-Garcia C; Ashkin E; Booth T; Brinkley-Rubinstein L; Fiellin DA; Fox AD; Maurer KF; Lin HJ; McCollister K; Murphy S; Morse DS; Shavit S; Wang K; Winkelman T; Wang EA
    J Subst Abuse Treat; 2021 Sep; 128():108315. PubMed ID: 33583610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
    Evans EA; Stopka TJ; Pivovarova E; Murphy SM; Taxman FS; Ferguson WJ; Bernson D; Santelices C; McCollister KE; Hoskinson R; Lincoln T; Friedmann PD;
    J Subst Abuse Treat; 2021 Sep; 128():108275. PubMed ID: 33483222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19.
    Harrington C; Bailey A; Delorme E; Hano S; Evans EA
    Subst Use Misuse; 2023; 58(2):266-274. PubMed ID: 36510800
    [No Abstract]   [Full Text] [Related]  

  • 5. Scoping review of interventions to link individuals to substance use services at discharge from jail.
    Grella CE; Ostlie E; Watson DP; Scott CK; Carnevale J; Dennis ML
    J Subst Abuse Treat; 2022 Jul; 138():108718. PubMed ID: 35012792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a cascade of care for opioid use disorder among individuals in jail.
    Ray B; Victor G; Cason R; Hamameh N; Kubiak S; Zettner C; Dunnigan M; Comartin E; Costello M
    J Subst Abuse Treat; 2022 Jul; 138():108751. PubMed ID: 35241352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts.
    Matsumoto A; Santelices C; Evans EA; Pivovarova E; Stopka TJ; Ferguson WJ; Friedmann PD
    Int J Drug Policy; 2022 Nov; 109():103823. PubMed ID: 35994938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.
    Banta-Green CJ; Williams JR; Sears JM; Floyd AS; Tsui JI; Hoeft TJ
    Drug Alcohol Depend; 2020 Feb; 207():107799. PubMed ID: 31865058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail.
    Zarkin GA; Orme S; Dunlap LJ; Kelly SM; Mitchell SG; O'Grady KE; Schwartz RP
    Drug Alcohol Depend; 2020 Dec; 217():108292. PubMed ID: 32992151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trial.
    McCollister KE; French MT; Freitas DM; Dennis ML; Scott CK; Funk RR
    Addiction; 2013 Dec; 108(12):2166-74. PubMed ID: 23961833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.
    Scott CK; Grella CE; Dennis ML; Carnevale J; LaVallee R
    Health Justice; 2022 Dec; 10(1):36. PubMed ID: 36538121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder.
    Evans EA; Wilson D; Friedmann PD
    Drug Alcohol Depend; 2022 Feb; 231():109254. PubMed ID: 35063323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
    Brezel ER; Powell T; Fox AD
    Subst Abus; 2020; 41(2):150-154. PubMed ID: 31800376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.
    Krawczyk N; Bandara S; Merritt S; Shah H; Duncan A; McEntee B; Schiff M; Ahmad NJ; Whaley S; Latimore A; Saloner B
    Addict Sci Clin Pract; 2022 Jun; 17(1):30. PubMed ID: 35655293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis.
    Lim S; Cherian T; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; Rosner Z; MacDonald R; Lee JD
    J Subst Use Addict Treat; 2024 Mar; 158():209254. PubMed ID: 38072387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders.
    Dennis M; Scott CK; Funk R
    Eval Program Plann; 2003 Aug; 26(3):339-352. PubMed ID: 30034059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery support specialists inside the jail: a program description of treatment engagement for opioid use disorder.
    Martin M; Phillips MA; Saxon M; Love K; Cessna L; Woodard DL; Page M; Curry K; Paone A; Pennington-Stallcup B; Riley W
    Int J Prison Health; 2021 Nov; 17(4):497-508. PubMed ID: 38902903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.
    McGladrey M; Kelsch J; Lofwall MR; Fanucchi LC; Walsh SL; Oser CB
    J Correct Health Care; 2024 Feb; 30(1):3-6. PubMed ID: 38150232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using recovery management checkups for primary care to improve linkage to alcohol and other drug use treatment: a randomized controlled trial three month findings.
    Scott CK; Dennis ML; Grella CE; Watson DP; Davis JP; Hart MK
    Addiction; 2023 Mar; 118(3):520-532. PubMed ID: 36208061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
    Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
    Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.